Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases the risk of developing hepatocellular carcinoma (HCC) in patients with type 2 diabetes, according to results of ...

Disability insurance applications and appeals (18.6%).

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

The preferred treatment for gay and bisexual men with prostate cancer may differ according to preferred sexual behavior, an analysis suggests.

The gender pay gap for US physicians hit 26% in 2024, which was an increase from the 23% pay gap observed in 2023, according to a report.

AI system combined with use of extended-reality headset effectively teaches surgeons without need for an instructor.

Community oncology practices in the US have been experiencing drug shortages that seriously impact cancer care delivery, a survey suggests.

The promising trial results may be a breakthrough for cisplatin-ineligible patients with muscle-invasive bladder cancer.

Stronger differential effect for CPAP seen for those without excessive sleepiness, without increased blood pressure.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit.